Relevance of the assessment of natriuretic peptide plasma concentrations in hypertensive pregnant women

Biomarkers. 2020 Sep;25(6):449-457. doi: 10.1080/1354750X.2020.1795264. Epub 2020 Jul 21.

Abstract

Assessment of the plasma concentrations of natriuretic peptides (NPs) is widely used to diagnose and evaluate the progression of cardiac failure, and their potential as markers of preeclampsia (PE) has been examined in recent years. It has been established that plasma concentrations of NPs do not change in the course of normal pregnancy. However, elevated levels of these peptides may have a prognostic value in patients with PE. This study presents information about the relevance of NPs assessment in the evaluation of physiological pregnancy, as well as in pregnancy complicated with arterial hypertension. The most commonly examined NPs is the N-terminal fragment of the brain natriuretic peptide (NT-proBNP), and it may be prognostic marker of PE and other complications of pregnancy.

Keywords: Eclampsia; gestational hypertension; hypertension; natriuretic peptides; preeclampsia.

MeSH terms

  • Adult
  • Biomarkers / blood*
  • Female
  • Gestational Age
  • Humans
  • Hypertension / blood*
  • Hypertension / pathology
  • Natriuretic Peptide, Brain / blood*
  • Pregnancy
  • Pregnancy Complications, Cardiovascular / blood*
  • Pregnancy Complications, Cardiovascular / pathology
  • Pregnant Women

Substances

  • Biomarkers
  • Natriuretic Peptide, Brain